NCT00836225 Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00833677 Community Based Participatory Research With Immigrant Chinese With Diabetes Status COMPLETED Phase NA
NCT00831779 Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00830076 A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) Status COMPLETED Phase PHASE1
NCT00824616 A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018) Status COMPLETED Phase PHASE2
NCT00823849 Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker Status COMPLETED Phase PHASE4
NCT00822211 Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy Status COMPLETED Phase PHASE3
NCT00821795 Veterans Inpatient Insulin Study and Transition to Outpatient Therapy Status COMPLETED Phase PHASE4
NCT00819325 Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients Status COMPLETED Phase PHASE4
NCT00818779 Direct Renin Inhibition Effects on Atherosclerotic Biomarkers Status COMPLETED Phase PHASE4
NCT00816010 Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes Status TERMINATED Phase NA
NCT00814372 Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin Status TERMINATED Phase PHASE2
NCT00814190 Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) Status COMPLETED Phase NA
NCT00813995 A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074) Status COMPLETED Phase PHASE3
NCT00812032 Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT00806585 Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007) Status TERMINATED Phase PHASE2
NCT00803920 Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide Status COMPLETED Phase N/A
NCT00799643 Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II Status COMPLETED Phase PHASE2/PHASE3